FDA Import Refusal 1FX-0365341-8/10002/4 — GLAXOSMITHKLINE PHARMACEUTICALSLTD
The FDA refused shipment 1FX-0365341-8/10002/4 from GLAXOSMITHKLINE PHARMACEUTICALSLTD (India) on Aug 25, 2026. The refused product falls under Drugs and Biologics — CEFIXIME (CEPHALOSPORINS). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 25, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 56CCY54 CEFIXIME (CEPHALOSPORINS)
- Charges
- 75